AU2007241026A1 - Pharmaceutical compositions for promoting wound healing - Google Patents

Pharmaceutical compositions for promoting wound healing Download PDF

Info

Publication number
AU2007241026A1
AU2007241026A1 AU2007241026A AU2007241026A AU2007241026A1 AU 2007241026 A1 AU2007241026 A1 AU 2007241026A1 AU 2007241026 A AU2007241026 A AU 2007241026A AU 2007241026 A AU2007241026 A AU 2007241026A AU 2007241026 A1 AU2007241026 A1 AU 2007241026A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
adenosine
chlorophenyl
ethoxy
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007241026A
Other languages
English (en)
Inventor
Martin W. Beasley
Edward Leung
Kevin H. Sills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
King Pharmaceuticals Research and Development Inc
Original Assignee
King Pharmaceuticals Research and Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Research and Development Inc filed Critical King Pharmaceuticals Research and Development Inc
Publication of AU2007241026A1 publication Critical patent/AU2007241026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AU2007241026A 2006-03-31 2007-03-30 Pharmaceutical compositions for promoting wound healing Abandoned AU2007241026A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78830306P 2006-03-31 2006-03-31
US60/788,303 2006-03-31
US11/729,624 US20070232561A1 (en) 2006-03-31 2007-03-29 Pharmaceutical compositions for promoting wound healing
US11/729,624 2007-03-29
PCT/US2007/007986 WO2007123740A2 (en) 2006-03-31 2007-03-30 Pharmaceutical compositions for promoting wound healing

Publications (1)

Publication Number Publication Date
AU2007241026A1 true AU2007241026A1 (en) 2007-11-01

Family

ID=38559987

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007241026A Abandoned AU2007241026A1 (en) 2006-03-31 2007-03-30 Pharmaceutical compositions for promoting wound healing

Country Status (6)

Country Link
US (2) US20070232561A1 (enExample)
EP (1) EP2001489A4 (enExample)
JP (1) JP2009532359A (enExample)
AU (1) AU2007241026A1 (enExample)
CA (1) CA2646446A1 (enExample)
WO (1) WO2007123740A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2461916T3 (es) * 2010-08-19 2014-05-21 Paul Hartmann Ag Apósito con contenido en espuma y base de pomada para la terapia por presión negativa
US20130295230A1 (en) * 2012-05-04 2013-11-07 Nutraceutical Corporation Sugar-free naturally preserved stevia supplement
US9023826B2 (en) 2012-10-12 2015-05-05 L'oreal S.A. Compositions containing adenosine and the hydrotropes caffeine and nicotinamide for cosmetic use
US9072919B2 (en) 2012-10-12 2015-07-07 L'oreal S.A. Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid
US9018177B2 (en) 2012-10-12 2015-04-28 L'oreal S.A. Cosmetic compositions for increasing bioavailability of the active compounds baicalin and/or vitamin C
US9107853B2 (en) 2012-10-12 2015-08-18 L'oreal S.A. Compositions containing phenolic compounds and hydrotropes for cosmetic use
EP2906547B2 (en) 2012-10-12 2022-10-26 L'Oréal Cosmetic compositions containing at least one hydrotrope and at least one active compound
US9669242B2 (en) 2013-07-01 2017-06-06 L'oreal Compositions containing at least two phenolic compounds, a lipid-soluble antioxidant and at least one hydrotrope for cosmetic use
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
WO2020157633A2 (en) * 2019-01-28 2020-08-06 Core Scientific Creations Ltd. Wound dressing compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
GB2318732A (en) * 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
IL161608A0 (en) * 2001-10-25 2004-09-27 King Pharmaceuticals Res & Dev Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines

Also Published As

Publication number Publication date
US20110144027A1 (en) 2011-06-16
EP2001489A4 (en) 2013-01-23
JP2009532359A (ja) 2009-09-10
CA2646446A1 (en) 2007-11-01
US20070232561A1 (en) 2007-10-04
EP2001489A2 (en) 2008-12-17
WO2007123740A2 (en) 2007-11-01
WO2007123740A3 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
US20110144027A1 (en) Pharmaceutical compositions for promoting wound healing
US10561607B2 (en) Pharmaceutical compositions comprising gels and methods for fabricating thereof
US12070442B2 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
ES2236733T3 (es) Foromulaciones cicatrizantes que contienen fibronectina de plasma humano.
US20050079147A1 (en) Wound healing compositions and uses
US9522165B2 (en) Formulation and method for the treatment of fungal nail infections
US20220192191A1 (en) Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms
US20230338455A1 (en) Pharmaceutical composition in the form of a hydrogel comprising orange-derived extracellular vesicles
US20170112936A1 (en) Pharmaceutical compositions comprising gels and methods for fabricating thereof
KR20170018852A (ko) 상처 치료를 위한 국소 조성물 및 방법
US11766421B2 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
US10456416B2 (en) Compositions and methods of treating microbes
US20220175829A1 (en) Antimicrobial Compositions
MX2011001812A (es) Composicion topica de hidrogel.
KR20180059748A (ko) 고농도 생물 발효 히알루론산 나트륨으로 구성된 국소성 중합체 기지 합성물 및 그 사용
WO2006069540A1 (fr) Systeme de distribution de medicament pour le traitement de brulures contenant du trehalose et de l’acide hyaluronique et son procede de fabrication
US20240108697A1 (en) Antimicrobial compositions
CN112263544B (zh) 一种盐酸利多卡因凝胶及其制备方法
Gupta et al. Pluronic and chitosan based in situ gel system for periodontal application
US20200155450A1 (en) Pharmaceutical compositions comprising gels and methods for fabricating thereof
CN117563004A (zh) 用于牙槽骨炎的药物组合物
RU2536266C2 (ru) Крем медицинского назначения, изготовленный с использованием фрамицетина сульфата и хитозана, и способ его изготовления
RU2349302C1 (ru) Фармацевтическая композиция для наружного применения "офломелид" при гнойно-воспалительных заболеваниях
Alani The ophthalmic rod: A new ophthalmic drug delivery system I
CN113082029B (zh) 一种伤口清洗消毒剂

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application